Cite
HARVARD Citation
Lukes, A. et al. (2021). O-136 Once-daily relugolix combination therapy results in sustained reduction in symptoms and improved quality of life in women with uterine fibroids treated over 52 weeks. Human reproduction. p. . [Online].